Accelerate your drug development pipeline with pharmaceutical‑grade Degarelix Acetate, engineered for U.S. FDA‑compliant hormone‑therapy programs. Ideal for Purchasing Managers, Technical Directors, and Operations Leaders who demand consistent potency, on‑time delivery, and transparent pricing.
Get Free Quote in 24 hIn 2025, 37 % of U.S. pharmaceutical firms reported project delays due to API supply chain issues. The most common roadblocks when sourcing Degarelix Acetate are:
Imagine a scenario where your R&D team must pause a Phase II trial because the API fails the HPLC purity test. The resulting delay can cost **$2.3 million** in lost market opportunity. That risk is avoidable.
| Parameter | Specification |
|---|---|
| CAS Number | 103192‑50‑3 |
| Chemical Name | Degarelix Acetate |
| Molecular Formula | C₆₈H₁₁₁N₁₈O₁₆·CH₃COO |
| Purity (HPLC) | ≥ 99.8 % (± 0.1 %) |
| Assay Method | Validated HPLC‑UV (220 nm) |
| Moisture Content | ≤ 0.5 % (Karl Fischer) |
| Particle Size (D₅₀) | 45 µm (± 5 µm) |
| Packaging | HDPE drums (25 kg) or sterile glass vials (5 g‑100 g) |
| Shelf Life | 24 months (stored ≤ 25 °C, protected from light) |
Scenario 1 – Oncology R&D (Phase II)
A mid‑size biotech in Boston needed 2 kg of Degarelix Acetate for a prostate‑cancer Phase II trial. Global Technology delivered 1.95 kg of API within 21 days, with assay 99.9 % and full FDA‑compliant documentation. The trial started on schedule, saving the client an estimated $1.8 M in delay costs.
Scenario 2 – Generic Manufacturer
CAS-102686-43-1-Degarelix-Acetate ALK-inhibitors-afuresertib-oncology-research Alpha-carotenoids-Alpha-hydroxyalprazolam-derivative ACTH-(3-24)-human-analog-research-peptide
A U.S. generic drug maker required a 10‑ton bulk supply for a 2026 market‑entry program. By leveraging our high‑speed 500 L reactor line and DDP shipping, we achieved a 30 % reduction in total landed cost versus the previous Asian supplier.
Each batch includes a Certificate of Analysis (CoA), GMP audit report, FDA DMF reference, MSDS, and a full chain‑of‑custody certificate. All documents are available in PDF and XML formats for easy ERP integration.
Yes. Our OEM service allows particle‑size distribution from 20 µm to 80 µm (D₅₀) and can accommodate sterile‑vial packaging on request.

Standard terms are 30 % T/T + 70 % L/C at sight. For qualified long‑term partners we offer Net 30 after the first successful delivery.
When requested, we ship Degarelix Acetate in insulated containers with gel packs, monitored by real‑time temperature loggers (range 2‑8 °C). A temperature‑deviation report is provided with every consignment.
Our MOQ for pharmaceutical‑grade Degarelix Acetate is 5 kg. For research‑grade material, the MOQ drops to 100 g.
Limited‑time offer: Free 250 mg sample + 30‑day money‑back guarantee on your first bulk order.
Contact Sales WhatsApp UsOr call us directly at +86 199 4383 0844
James Liu, Procurement Lead – BioNova:
“The API arrived on‑time and matched the CoA perfectly. We saved **15 %** on logistics by using their DDP option.”
Sarah Patel, Technical Director – Helix Therapeutics:
“Technical support answered our HPLC method questions within 2 hours. The data integrity gave us confidence to file IND‑submission on schedule.”
Michael O’Connor, Operations Manager – PurePharm:
“Switching to Global Technology reduced our lead time from 8 weeks to 3 weeks, accelerating our product launch by **45 days**.”
Dr. Alan Cheng, Ph.D. – Senior API Development Engineer with 15 years of experience in peptide synthesis, GMP compliance, and international pharmaceutical sourcing. Former Lead Scientist at a top‑10 U.S. biotech firm and current Technical Advisor for Global Technology Co., Ltd.
Published author of “Advanced Peptide Manufacturing for Oncology” (Springer, 2023) and regular contributor to PharmaTech Journal.
Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
All product information complies with U.S. FDA, EMA, and local import regulations. Prices are indicative; final quotation provided after specification confirmation.